Cite
Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux.
MLA
Palmieri, B., et al. “Fixed Combination of Hyaluronic Acid and Chondroitin-Sulphate Oral Formulation in a Randomized Double Blind, Placebo Controlled Study for the Treatment of Symptoms in Patients with Non-Erosive Gastroesophageal Reflux.” European Review for Medical & Pharmacological Sciences, vol. 17, no. 24, Dec. 2013, pp. 3272–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=93387423&authtype=sso&custid=ns315887.
APA
Palmieri, B., Merighi, A., Corbascio, D., Rottigni, V., Fistetto, G., & Esposito, A. (2013). Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux. European Review for Medical & Pharmacological Sciences, 17(24), 3272–3278.
Chicago
Palmieri, B., A. Merighi, D. Corbascio, V. Rottigni, G. Fistetto, and A. Esposito. 2013. “Fixed Combination of Hyaluronic Acid and Chondroitin-Sulphate Oral Formulation in a Randomized Double Blind, Placebo Controlled Study for the Treatment of Symptoms in Patients with Non-Erosive Gastroesophageal Reflux.” European Review for Medical & Pharmacological Sciences 17 (24): 3272–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=93387423&authtype=sso&custid=ns315887.